Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

2.33
-0.1600-6.43%
Post-market: 2.330.00000.00%16:20 EDT
Volume:1.84M
Turnover:4.36M
Market Cap:203.40M
PE:-2.08
High:2.51
Open:2.38
Low:2.32
Close:2.49
Loading ...
Aug 18, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 16, 2022

Major Issues Report

8-K - Current report
Aug 16, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 12, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2022

Major Issues Report

8-K - Current report
Jun 17, 2022

Major Issues Report

8-K - Current report
Jun 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 01, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 21, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 07, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals